Active

Celiac

Investor type

VC

Founded

1990

AUM

$15 M

Location

Los Angeles, California, United States

Investment Ticket

$10-50 m

Investment Stage

Pre-seed Seed

Region of investment

North America
Investor profile last updated: 05 August, 2026

Profile

Celiac is a nonprofit organization headquartered in the USA, primarily focused on raising awareness and supporting research related to celiac disease. Established to serve the needs of people with the condition, the organization offers educational resources, advocacy, and a patient registry to aid in scientific studies. It is composed of a diverse team of leaders, advisors, and staff dedicated to providing accurate information and support to those affected by celiac disease and their families.

The organization’s activities include advancing research through patient registries and trials, as well as providing gluten-free resources and policy advocacy. Their educational efforts encompass virtual events and the dissemination of research findings associated with celiac disease. Though not an investment firm, Celiac channels its contributions and resources towards impactful programs and initiatives aimed at improving the lives of individuals with celiac disease.

With supportive efforts from donors and financial backing, Celiac helps foster a collaborative network of patients, medical professionals, and researchers. Their strategic partnerships and sponsorships enable them to drive initiatives and promote a deeper understanding of celiac disease through various campaigns and educational outreach programs.

Industry

Biotechnology Business Services (B2B) Digital Healthcare Services HealthTech Medical Devices Life Sciences

Celiac Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Celiac Disease Foundation Impact Fund
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Pre-seed
Seed
North America
$5-10 m
$15 M
March 2026

Contacts

Name
Title
Email
avatar
Elaine Monarch Founder/retired
Founder/retired
e•••@•••
avatar
Janie Magill Director of Development
Director of Development
j•••@•••
Upgrade to see contacts
avatar
GyAqFiE5N4Hxw32c GyAqFiE5N4Hxw32c
GyAqFiE5N4Hxw32c
avatar
GyAqFiE5N4Hxw32c GyAqFiE5N4Hxw32c
GyAqFiE5N4Hxw32c
avatar
GyAqFiE5N4Hxw32c GyAqFiE5N4Hxw32c
GyAqFiE5N4Hxw32c
Investment-team contacts for Celiac — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Celiac

Celiac is a venture capital firm. It backs companies at Pre-seed and Seed, writing tickets of $10-50 m.
Celiac is located in Los Angeles, California, United States.
Celiac was founded in 1990.
Celiac invests in companies and startups in Biotechnology, Business Services (B2B), Digital, Healthcare Services, HealthTech, Medical Devices, Life Sciences.
Celiac invests in companies and startups in North America.
Celiac invests in companies and startups at Pre-seed, Seed.
Celiac usually invests $10-50 m on average.
Celiac has around $15m assets under management.
Celiac last fund was created/launched in 2026-03-18
Celiac can be reached through its website celiac.org, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Celiac — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Celiac directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 05 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.